Drugs.com FDA MedWatch AlertsOriginal article
FAERS Receives Increased Reports of Allergic/Hypersensitivity Reactions with One Lot of Immune Globulin Intravenous (IGIV)
RegulatoryImmune Globulin Intravenous (IGIV)Negative
AI Analysis
Summary
The FDA's FAERS system has received increased reports of allergic and hypersensitivity reactions following infusion of a specific lot of Immune Globulin Intravenous (IGIV). The alert was issued to healthcare professionals and consumers on October 6, 2026.
Outcome Details
Increased adverse event reports of allergic/hypersensitivity reactions associated with a specific lot
Importance:5/10
Sentiment:
-0.70
safety alertadverse eventsFAERSallergic reactionproduct safety
Read the original article
Published by Drugs.com FDA MedWatch Alerts on October 6, 2026 5:40 PM